Program Description

Each year, approximately 2 million people in the United States are stricken with venous thromboembolism (VTE); up to 600,000 of these patients will go on to develop a pulmonary embolism (PE). The mortality associated with PE is unacceptably high and results in as many as 200,000 deaths. It has been shown that the most effective means of reducing mortality of PE and morbidity from post-thrombotic syndrome is to have in place a comprehensive plan for prophylaxis of at-risk patients. However, treatment guidelines should also address how to provide optimal care for patients who develop a VTE, particularly in light of the high mortality associated with this complication.

This program will address current options for the prophylaxis and treatment of VTE. Participants should be able to use the information presented to establish prevention and treatment guidelines in their own institutions. Practical approaches for the prevention and management of VTE will be illustrated using patient case studies.